215 related articles for article (PubMed ID: 25428336)
1. Review of the regulations for clinical research in herbal medicines in USA.
Tang TY; Li FZ; Afseth J
Chin J Integr Med; 2014 Dec; 20(12):883-93. PubMed ID: 25428336
[TBL] [Abstract][Full Text] [Related]
2. Current regulatory toxicology perspectives on the development of herbal medicines to prescription drug products in the United States.
Wu KM; Ghantous H; Birnkrant DB
Food Chem Toxicol; 2008 Aug; 46(8):2606-10. PubMed ID: 18614266
[TBL] [Abstract][Full Text] [Related]
3. [Research progress on current pharmacokinetic evaluation of Chinese herbal medicines].
Li G; Zhao H; Yang J
Zhongguo Zhong Yao Za Zhi; 2011 Mar; 36(5):644-9. PubMed ID: 21657088
[TBL] [Abstract][Full Text] [Related]
4. [Dissection of differences and similarities of botanical drugs in European Union, US and Canada].
He Y; Zhao L; Ye Z; Guo Z; Sun H
Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(19):2747-50. PubMed ID: 22242441
[TBL] [Abstract][Full Text] [Related]
5. Essays in public health and preventive medicine. A call to Pharms: the need for tighter FDA regulation of the neutraceutical industry.
Dobrin J
Mt Sinai J Med; 2006 Mar; 73(2):565-6. PubMed ID: 16685816
[No Abstract] [Full Text] [Related]
6. Contributions of Indian Council of Medical Research (ICMR) in the area of Medicinal plants/Traditional medicine.
Tandon N; Yadav SS
J Ethnopharmacol; 2017 Feb; 197():39-45. PubMed ID: 27452657
[TBL] [Abstract][Full Text] [Related]
7. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
Rossen BR
Food Drug Law J; 2009; 64(1):183-223. PubMed ID: 19998746
[TBL] [Abstract][Full Text] [Related]
8. Adverse interactions between herbal and dietary substances and prescription medications: a clinical survey.
Bush TM; Rayburn KS; Holloway SW; Sanchez-Yamamoto DS; Allen BL; Lam T; So BK; Tran de H; Greyber ER; Kantor S; Roth LW
Altern Ther Health Med; 2007; 13(2):30-5. PubMed ID: 17405676
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic Herb-Drug Interactions: Insight into Mechanisms and Consequences.
Oga EF; Sekine S; Shitara Y; Horie T
Eur J Drug Metab Pharmacokinet; 2016 Apr; 41(2):93-108. PubMed ID: 26311243
[TBL] [Abstract][Full Text] [Related]
10. Future development of global regulations of Chinese herbal products.
Fan TP; Deal G; Koo HL; Rees D; Sun H; Chen S; Dou JH; Makarov VG; Pozharitskaya ON; Shikov AN; Kim YS; Huang YT; Chang YS; Jia W; Dias A; Wong VC; Chan K
J Ethnopharmacol; 2012 Apr; 140(3):568-86. PubMed ID: 22373513
[TBL] [Abstract][Full Text] [Related]
11. Botanical medicines--the need for new regulations.
Marcus DM; Grollman AP
N Engl J Med; 2002 Dec; 347(25):2073-6. PubMed ID: 12490692
[No Abstract] [Full Text] [Related]
12. [Discussion about traditional Chinese medicine pharmacokinetics study based on first botanical drug approved by FDA].
Huang F
Zhongguo Zhong Yao Za Zhi; 2010 Apr; 35(7):932-5. PubMed ID: 20575403
[TBL] [Abstract][Full Text] [Related]
13. Herbal medicines in Malaysia.
Ang HH
Clin Pharmacol Ther; 2005 May; 77(5):451. PubMed ID: 15900291
[No Abstract] [Full Text] [Related]
14. Regulatory issues concerning the safety, efficacy and quality of herbal remedies.
Rousseaux CG; Schachter H
Birth Defects Res B Dev Reprod Toxicol; 2003 Dec; 68(6):505-10. PubMed ID: 14745988
[TBL] [Abstract][Full Text] [Related]
15. Botanical drugs: a future for herbal medicines.
Li W
J Contemp Health Law Policy; 2002; 19(1):117-49. PubMed ID: 12733224
[No Abstract] [Full Text] [Related]
16. Lessons learned from independent central review.
Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
[TBL] [Abstract][Full Text] [Related]
17. Pharmacovigilance of herbal medicine.
Shaw D; Graeme L; Pierre D; Elizabeth W; Kelvin C
J Ethnopharmacol; 2012 Apr; 140(3):513-8. PubMed ID: 22342381
[TBL] [Abstract][Full Text] [Related]
18. Herbal medicine development: a plea for a rigorous scientific foundation.
Lietman PS
Am J Ther; 2012 Sep; 19(5):351-6. PubMed ID: 22964559
[TBL] [Abstract][Full Text] [Related]
19. [Potential risks, adverse effects and drug interactions associated with herbal medicine in dental patients].
Zlotogorski Hurvitz A; Littner M
Refuat Hapeh Vehashinayim (1993); 2004 Apr; 21(2):25-41, 97. PubMed ID: 15503544
[TBL] [Abstract][Full Text] [Related]
20. American Society of Clinical Oncology policy statement: oversight of clinical research.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
